| Literature DB >> 33083356 |
Aleksandar Stepanović1, Marina Nikitović1,2, Andrija Bogdanović2,3, Danica Grujičić2,4.
Abstract
We describe long-lasting and incompletely resolved thrombocytopenia after transient profound pancytopenia in a 62-year-old female patient with glioblastoma after short-term radiotherapy with temozolomide. Pancytopenia was present for more than 4 weeks and thrombocytopenia for more than 6 months, without platelet recovery to normal levels. LEARNING POINTS: Some patients may experience severe haematological manifestations after even short-term radiotherapy with temozolomide.In everyday practice, clinical models precisely predicting the haematological toxicity of concomitant treatment with temozolomide and radiotherapy is necessary, especially in countries where genetic tests are not available.Incomplete recovery of the cells of a particular bloodline over a long period may necessitate permanent discontinuation of chemotherapy or radiotherapy. © EFIM 2020.Entities:
Keywords: Glioblastoma; pancytopenia; temozolomide; thrombocytopenia
Year: 2020 PMID: 33083356 PMCID: PMC7546554 DOI: 10.12890/2020_001785
Source DB: PubMed Journal: Eur J Case Rep Intern Med ISSN: 2284-2594